Northeast Pharmaceutical Group Dividends and Buybacks
Dividend criteria checks 3/6
Northeast Pharmaceutical Group is a dividend paying company with a current yield of 1.92% that is well covered by earnings.
Key information
1.9%
Dividend yield
0.2%
Buyback Yield
| Total Shareholder Yield | 2.1% |
| Future Dividend Yield | n/a |
| Dividend Growth | 46.8% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.100 |
| Payout ratio | 41% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, 000597 has been paying a dividend for less than 10 years.
Growing Dividend: 000597's dividend payments have increased, but the company has only paid a dividend for 4 years.
Dividend Yield vs Market
| Northeast Pharmaceutical Group Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (000597) | 1.9% |
| Market Bottom 25% (CN) | 0.6% |
| Market Top 25% (CN) | 2.2% |
| Industry Average (Pharmaceuticals) | 1.7% |
| Analyst forecast (000597) (up to 3 years) | n/a |
Notable Dividend: 000597's dividend (1.92%) is higher than the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 000597's dividend (1.92%) is low compared to the top 25% of dividend payers in the CN market (2.15%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (41.2%), 000597's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (28.9%), 000597's dividend payments are well covered by cash flows.